MDLN - Medline Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$48.91
DETAILS
HIGH:
$60.00
LOW:
$38.00
MEDIAN:
$48.50
CONSENSUS:
$48.91
UPSIDE:
32.15%
| Metric | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q3 | 2024 Q2 |
|---|---|---|---|---|---|---|---|
| Revenue | |||||||
| Revenue | 7,352 | 7,787 | 7,115 | 6,886 | 6,644 | 6,388 | 6,185 |
| Cost of Revenue | 5,687 | 5,873 | 5,417 | 5,157 | 4,995 | 4,804 | 4,691 |
| Gross Profit | 1,665 | 1,914 | 1,698 | 1,729 | 1,649 | 1,584 | 1,494 |
| Operating Expenses | |||||||
| R&D Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A Expenses | 1,228 | 1,265 | 1,116 | 1,086 | 1,100 | 988 | 976 |
| Other Expenses | 15 | 224 | 8 | 14 | (42) | 22 | 2 |
| Operating Expenses | 1,243 | 1,489 | 1,124 | 1,100 | 1,058 | 1,010 | 978 |
| Operating Income | |||||||
| Operating Income | 422 | 425 | 574 | 629 | 591 | 574 | 516 |
| Interest Expense | 136 | 0 | 228 | 233 | 214 | 174 | 267 |
| Interest Income | 0 | 0 | 35 | 30 | 34 | 73 | 75 |
| Profitability | |||||||
| EBITDA | 676 | 601 | 826 | 842 | 838 | 760 | 806 |
| EBIT | 422 | 425 | 573 | 592 | 591 | 512 | 567 |
| Income Before Tax | 291 | 206 | 345 | 359 | 338 | 338 | 300 |
| Income Tax Expense | 52 | 26 | 23 | 26 | 16 | 14 | 8 |
| Net Income | 129 | 180 | 322 | 333 | 322 | 324 | 292 |
| Per Share Data | |||||||
| EPS (Basic) | 0.16 | 0.22 | 0.41 | 0.42 | 0.40 | 0.41 | 0.37 |
| EPS (Diluted) | 0.16 | 0.22 | 0.41 | 0.42 | 0.40 | 0.41 | 0.37 |
| Shares Outstanding | 819 | 812.0 | 787.1 | 787.1 | 799.8 | 787.1 | 787.1 |
| Metric | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Current Assets | |||||
| Cash & Cash Equivalents | 2,236 | 1,939 | 955 | 584 | 0 |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 3,674 | 3,533 | 3,425 | 3,340 | 0 |
| Inventory | 4,807 | 4,769 | 4,752 | 4,662 | 0 |
| Other Current Assets | 463 | 438 | 426 | 361 | 0 |
| Total Current Assets | 11,180 | 10,679 | 9,558 | 8,947 | 0 |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 4,758 | 4,778 | 4,690 | 4,672 | 0 |
| Goodwill | 21,793 | 8,079 | 8,069 | 8,069 | 0 |
| Intangible Assets | 0 | 13,893 | 14,068 | 14,246 | 0 |
| Long-Term Investments | 0 | 0 | 11 | 19 | 0 |
| Other Non-Current Assets | 446 | 1,055 | 487 | 475 | 0 |
| Total Non-Current Assets | 27,834 | 27,805 | 27,325 | 27,481 | 0 |
| Total Assets | 39,014 | 38,484 | 36,883 | 36,428 | 0 |
| Current Liabilities | |||||
| Account Payables | 932 | 961 | 990 | 919 | 0 |
| Short-Term Debt | 77 | 77 | 149 | 145 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 1,527 | 0 | 1,087 | 937 | 0 |
| Total Current Liabilities | 2,536 | 2,490 | 2,612 | 2,351 | 0 |
| Non-Current Liabilities | |||||
| Long-Term Debt | 12,495 | 12,484 | 16,501 | 16,501 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 4,634 | 4,224 | 629 | 625 | (16,158) |
| Total Non-Current Liabilities | 17,129 | 16,708 | 17,130 | 17,126 | (16,158) |
| Total Liabilities | 19,665 | 19,198 | 19,742 | 19,477 | (16,158) |
| Stockholders' Equity | |||||
| Common Stock | 0 | 0 | 16,722 | 16,522 | 0 |
| Retained Earnings | 122 | (7) | 0 | 0 | 0 |
| Accumulated Other Comprehensive Income | 18 | 27 | 52 | 62 | 16,158 |
| Total Stockholders' Equity | 11,272 | 10,737 | 17,141 | 16,951 | 16,158 |
| Total Liabilities & Equity | 39,014 | 38,484 | 36,883 | 36,428 | 0 |
| Debt Metrics | |||||
| Total Debt | 12,572 | 12,561 | 16,650 | 16,646 | 0 |
| Net Debt | 10,336 | 10,622 | 15,695 | 16,062 | 0 |
| Metric | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q3 |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Net Income | 129 | 180 | 322 | 333 | 322 | 324 |
| Depreciation & Amortization | 254 | (91) | 253 | 250 | 247 | 248 |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Working Capital | (161) | (282) | 1 | (503) | 1 | 62 |
| Other Non-Cash Items | 153 | 422 | 60 | 163 | 66 | 88 |
| Operating Cash Flow | 412 | 229 | 636 | 243 | 636 | 722 |
| Investing Activities | ||||||
| Capital Expenditure | (96) | 342 | (101) | (140) | (101) | (107) |
| Acquisitions | 0 | (6) | 0 | 0 | 0 | (890) |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales/Maturities of Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | (474) | 0 | 6 | 0 | (1) |
| Investing Cash Flow | (96) | (138) | (101) | (134) | (101) | (998) |
| Financing Activities | ||||||
| Net Debt Issuance | 0 | (4,049) | (24) | 5 | (24) | (513) |
| Stock Repurchased | 0 | 0 | (18) | 3 | (18) | (3) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (10) | (96) | (119) | (184) | (119) | (42) |
| Financing Cash Flow | (13) | 897 | (161) | (176) | (161) | (558) |
| Cash Position | ||||||
| Net Change in Cash | 296 | (955) | 371 | 584 | (250) | 0 |
| Cash at Beginning | 1,942 | 955 | 584 | 0 | 250 | 0 |
| Cash at End | 2,238 | 0 | 955 | 584 | 0 | 0 |
| Free Cash Flow | 316 | 571 | 535 | 103 | 535 | 615 |
| Key Metrics | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q3 | 2024 Q2 |
|---|---|---|---|---|---|---|---|
| Income Statement | |||||||
| Revenue | 7,352 | 7,787 | 7,115 | 6,886 | 6,644 | 6,388 | 6,185 |
| Gross Profit | 1,665 | 1,914 | 1,698 | 1,729 | 1,649 | 1,584 | 1,494 |
| Operating Income | 422 | 425 | 574 | 629 | 591 | 574 | 516 |
| Net Income | 129 | 180 | 322 | 333 | 322 | 324 | 292 |
| EPS (Diluted) | 0.16 | 0.22 | 0.41 | 0.42 | 0.40 | 0.41 | 0.37 |
| Balance Sheet | |||||||
| Cash & Equivalents | 2,236 | 1,939 | 955 | 584 | 0 | ||
| Total Assets | 39,014 | 38,484 | 36,883 | 36,428 | 0 | ||
| Total Debt | 12,572 | 12,561 | 16,650 | 16,646 | 0 | ||
| Stockholders' Equity | 11,272 | 10,737 | 17,141 | 16,951 | 16,158 | ||
| Cash Flow | |||||||
| Operating Cash Flow | 412 | 229 | 636 | 243 | 636 | 722 | |
| Capital Expenditure | (96) | 342 | (101) | (140) | (101) | (107) | |
| Free Cash Flow | 316 | 571 | 535 | 103 | 535 | 615 | |